Medical Device News Magazine

Dr Richard Kim Joins the Healthily Board

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Dr Richard Kim, an internationally renowned physician executive specialising in global healthcare strategy and digital health, is the latest medical specialist to join the Clinical Advisory Board at Healthily, the consumer digital healthcare company with one of the world’s leading artificial intelligence (AI) symptom checkers.

A US-based leader in employer wellbeing strategy and designing solutions for the next generation of healthcare delivery, Dr Kim most recently served as Chief Medical Officer at American Express. Here he led global health and safety programmes, and managed legal and labour complexities related to local government health and welfare requirements in Europe, Asia and the Americas.

During the COVID-19 pandemic, Dr Kim developed health and safety protocols and policies to protect Amex employees and customers, while maintaining business operations that yielded historic quarterly revenues. He also designed customer and employee safety policies for the US Open Tennis tournament, Wimbledon and the London Film Festival.

Prior to this, Dr Kim served as Associate Medical Director at Goldman Sachs, Executive Director at New York-Presbyterian Hospital in New York City and Medical Director at The Coca-Cola Company through Emory Healthcare.

Formerly Assistant Professor at Emory University, Dr Kim practised medicine at Eagle Hospital Physicians in Atlanta and Healthcare Partners in Los Angeles. He holds an MD from the Emory University School of Medicine, an MBA in strategy and business development from the Goizueta Business School at Emory University and a BA in Microbiology from Miami University.

A partnership in safety

With safety at the heart of everything it does, Healthily is delighted that Dr Kim’s wealth of experience will now be employed to assist its Clinical Advisory Board (CAB), a group of independent medical experts that ensures Healthily products and services meet the highest possible clinical standards.

Healthily was the first company to create an AI self-assessment tool with a CAB to independently scrutinise its clinical quality and efficacy. With the help of the CAB and an expert in-house medical team, Healthily became one of the first self-care apps to be self-certified as a Class I medical device in the EU and obtained the CE mark – indicating it complies with applicable EU directives and regulations and meets specific standards of performance, quality, safety and efficacy.

Dr Kim will serve on the board with chairperson Dr Mark Davies, Chief Medical Officer of IBM (EMEA), IBM Watson and formerly National Clinical Director for the NHS, alongside other renowned medical leaders. He will advise Healthily on strategy and business development with US healthcare providers and payers.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”